GEFITINIB 250 mg (Geffy) x 30 Tablets

GEFITINIB 250 mg (Geffy) x 30 Tablets

RXPrescription Mandatory

Gefitinib 250 mg Tablet is a targeted anticancer medicine used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations. It works by blocking the EGFR protein, helping to slow or stop the growth of cancer cells.

Manufacturer Intas Pharmaceutical
Generic Name Gefitinib
Strength 250mg
Pack size 30 Tablets
Used For Non-small cell lung cancer (NSCLC)
Availability In Stock
Shipping to USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries.

Ask Price on WhatsApp

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support

Generic GEFITINIB 250 mg Price in Other Currencies

Package USD GBP AUD PHP TND KRW RON HKD MYR THB SGD AED SAR QAR KWD
30 Tablets $100 £74 A$139 ₱6,269 د.ت291.10 ₩133,910 lei 453 HK$784 RM407 ฿3,302 S$127 د.إ367.30 ر.س375.50 ر.ق364.10 د.ك30.500

Uses of GEFITINIB 250 mg

  • Treats non-small cell lung cancer (NSCLC).
  • Used in EGFR mutation-positive lung cancer.
  • Used in advanced or metastatic cases.
  • Helps control disease progression.

Benefits of GEFITINIB 250 mg

  • Slows tumor growth in EGFR-positive cancer.
  • Helps shrink lung tumors.
  • Improves breathing and symptoms in some patients.
  • Oral targeted therapy option.
  • Delays disease progression.

How does it work?

Gefitinib is a targeted cancer medicine that blocks the EGFR (epidermal growth factor receptor) tyrosine kinase. This stops signals that cancer cells need to grow and divide, thereby slowing tumor progression.

Precautions

  • Take exactly as prescribed, with or without food.
  • Do not skip or stop doses suddenly.
  • Monitor liver function regularly.
  • Inform your doctor about lung, liver, or eye problems.
  • Tell your doctor about all medicines you are taking.
  • Report severe skin rash, breathing problems, or diarrhea immediately.

Author

Reviewed By

Dr. Ashish Kumar

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.

Disclaimer

All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.

Contact on Whatsapp